Summary & Overview
CPT 45190: Transanal Destruction of Rectal Tumor
CPT code 45190 identifies transanal destruction of a rectal tumor using techniques such as electrodesiccation, electrosurgery, laser ablation or resection, and cryosurgery. This procedure code is important for surgical, oncologic and colorectal service lines because it captures minimally invasive tumor destruction in the distal large intestine and drives facility and professional billing for these targeted interventions. Nationally, accurate use of this code affects claims processing, quality measurement, and aggregated utilization tracking for rectal tumor management.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for transanal tumor destruction, common settings where the procedure is performed, and the billing and coding elements that influence coverage and reimbursement. The publication summarizes benchmark metrics, common modifier usage, and payer coverage patterns where available, and it highlights policy considerations relevant to hospital and ambulatory surgery billing workflows. The content is intended to support coding accuracy, claims preparation, and administrative planning for providers and billing teams working in colorectal, surgical oncology, and procedural gastroenterology service lines.
Billing Code Overview
CPT code 45190 describes destruction of a tumor in the rectum performed via a transanal approach through the anus. The procedure may use methods such as electrodesiccation, electrosurgery, laser ablation, laser resection, or cryosurgery to eliminate the lesion.
-
Service type: Surgical destruction of rectal tumor via transanal approach
-
Typical site of service: Ambulatory surgery center or hospital operating room, performed transanally
Clinical & Coding Specifications
Clinical Context
A typical patient is a 62-year-old individual presenting with rectal bleeding, change in bowel habits, or a palpable rectal mass on digital rectal exam. After endoscopic evaluation (flexible sigmoidoscopy or colonoscopy) identifies a localized rectal tumor or premalignant lesion within reach of a transanal approach, the patient is scheduled for a transanal tumor destruction procedure. The patient undergoes preoperative assessment, informed consent, and bowel preparation as indicated. In the operating room or procedure suite, the patient is positioned in lithotomy or prone jackknife position. Under appropriate anesthesia (conscious sedation or general), a transanal approach is used to visualize the lesion with anoscope or proctoscope. The provider selects a destruction modality—electrodesiccation, electrosurgery, laser ablation/resection, or cryosurgery—based on lesion size, depth, and location. Hemostasis is achieved and specimens are sent for pathology if resection fragments are obtained. Post-procedure monitoring occurs in the recovery area with discharge instructions for analgesia, wound care, and follow-up with pathology and colorectal surgery. Typical site of service is an ambulatory surgery center or hospital operating room. Service type: invasive surgical/procedural destruction of rectal tumor via transanal approach.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or complexity substantially exceeds typical for (document specific reasons). |